A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
| Share Statistics | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7.3 | $288.9 | 5% |
|
| Shares Out (Mil) | 8.7 | 54.0 | 19% |
|
| Institutional Ownership | 39.8% | 93.1% | 16% |
|
| Float (Mil) | 12.2 | 41.4 | 22% |
|
| Beta | 0.68 | 0.94 | 40% |
|
| Avg Daily Volume (000s) | 196 | 480 | 45% |
|
| Price Change (52-week) |
(56.2%) | 59.9% | 13% |
|
| Growth | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 31.3% | 14.1% | 90% |
|
| Net Income (5yr) | 18.3% | (10.1%) | 70% |
|
| EPS (5yr) | 33.5% | 15.9% | 84 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.7%) | (15.6%) | 47% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.270) | ($1.700) | ($0.800) | |
| Month Ago EPS | ($0.270) | ($1.700) | ($0.800) | |
| # Rev Up | na | 1 | 1 | |
| # Rev Down | na | 0 | 0 | |
| Three Months Ago EPS | ($0.270) | ($1.700) | ($0.800) | |
| Year/Year Chg | (55.5%) | (5.5%) | (69.4%) | |
| Financials | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $4 | $37 | 5% |
|
| Net Income (TTM) (Mil) | ($9) | ($43) | 30% |
|
| EPS (TTM) | ($1.078) | ($1.500) | 20% |
|
| Operating Cash Flow (TTM) (Mil) | ($14) | ($31) | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $2 | $4 | 19% |
|
| Enterprise Value (Q1) (Mil) | $10 | $190 | 7% |
|
| Valuation | EVGN | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.84 | na |
|
| P/E | na | 20.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | EVGN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (67.6%) | 66.9% | 2% |
|
| Net Margin | (547.6%) | (74.2%) | 1% |
|
| ROA | (23.9%) | (47.7%) | 19% |
|
| ROE | (141.8%) | (55.0%) | 6% |
|
| Liabilities to Assets | 40.3% | 29.6% | 31% |
|
| F-Score | 1 | 3 | 1% |
|
Evogene Ltd. did not pass any screens on 9/2/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
